Epigenetic DNA Modifications Upregulate SPRY2 in Human Colorectal Cancers

Conventional wisdom is that Sprouty2 (SPRY2), a suppressor of Receptor Tyrosine Kinase (RTK) signaling, functions as a tumor suppressor and is downregulated in many solid tumors. We reported, for the first time, that increased expression of SPRY2 augments cancer phenotype and Epithelial-Mesenchymal-...

Descripción completa

Detalles Bibliográficos
Autores principales: Stuckel, Alexei J., Zeng, Shuai, Lyu, Zhen, Zhang, Wei, Zhang, Xu, Dougherty, Urszula, Mustafi, Reba, Zhang, Qiong, Joshi, Trupti, Bissonnette, Marc, Choudhury, Samrat Roy, Khare, Sharad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534322/
https://www.ncbi.nlm.nih.gov/pubmed/34685612
http://dx.doi.org/10.3390/cells10102632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534322/
https://www.ncbi.nlm.nih.gov/pubmed/34685612
http://dx.doi.org/10.3390/cells10102632

Ejemplares similares